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Abstract
While basic mechanisms of several major molecular chaperones are well understood, this machinery has been known to be
involved in folding of only limited number of proteins inside the cells. Here, we report a chaperone type of protein folding
facilitated by interaction with RNA. When an RNA-binding module is placed at the N-terminus of aggregation-prone target
proteins, this module, upon binding with RNA, further promotes the solubility of passenger proteins, potentially leading to
enhancement of proper protein folding. Studies on in vitro refolding in the presence of RNA, coexpression of RNA molecules
in vivo and the mutants with impaired RNA binding ability suggests that RNA can exert chaperoning effect on their bound
proteins. The results suggest that RNA binding could affect the overall kinetic network of protein folding pathway in favor of
productive folding over off-pathway aggregation. In addition, the RNA binding-mediated solubility enhancement is
extremely robust for increasing soluble yield of passenger proteins and could be usefully implemented for high-throughput
protein expression for functional and structural genomic research initiatives. The RNA-mediated chaperone type presented
here would give new insights into de novo folding in vivo.
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Introduction
Folding of substantial fraction of newly synthesized proteins has
been known to be assisted by molecular chaperones in the highly
crowded cytosolic environment [1,2]. Surprisingly, however,
biochemical and genetic analyses have shown that only a limited
number of proteins are dependent on the molecular chaperones
[2–5], suggesting that other chaperone types and mechanisms
might exist in vivo. Consistent with the restricted role of molecular
chaperones, coexpression of molecular chaperones for the
production of functional heterologous proteins in E. coli cytosol
has been found effective only for limited cases [6]. Alternatively,
fusion to highly soluble carriers such as maltose-binding protein
(MBP) and NusA provides practical means to circumvent inclusion
body formation [7–10]. Nevertheless, production of properly
folded proteins of heterologous origin in E. coli host is still difficult,
necessitating identification of more efficient folding vehicle for the
high-throughput supply of functional proteins.
Molecular chaperones transiently bind to and shield the
exposed hydrophobic surfaces by direct hydrophobic interactions
and/or encapsulation to prevent misfolding and aggregation,
leading to proper folding [2,11]. On the other hand, charge is one
of the crucial factors determining the solubility of proteins in the
aqueous environment [12–14]. Electrostatic repulsions by charged
residues can counteract intermolecular hydrophobic interactions
of their linked residues [15]. Anionic tags promote solubility of
their linked proteins [16,17]. Consistently, the charges of fusion
partners are closely correlated with their solubilizing ability
[7,18,19]. These findings indicate that the hydrophobic shielding
is not a sole determinant of stabilizing aggregation-prone folding
intermediates against aggregation, and other mechanism may exist
for folding of nascent proteins inside the cells.
Polyanions, including RNA and DNA, can accelerate the
refolding rate of the Arc repressor dimer by nonspecific
electrostatic interactions in vitro [20]. The intrinsically disordered
proteins and domains form ordered structure or fold upon binding
to its cognate RNA [13,21]. In particular, ribosome and its
component 23S rRNA have been reported to behave like
molecular chaperones in vitro in a trans-acting mode [22,23].
However, their relevance to de novo folding in vivo still remains
largely unknown. All newly synthesized polypeptides are tightly
linked to ribosomes during their biogenesis and folding process.
Nevertheless, the roles of ribosomes in the aggregation and folding
behavior of their linked aggregation-prone polypeptides in a cis-
acting manner have been poorly understood. Notably, ribosomes
are RNP complexes in which RNAs are major components and
basic structural frames [24]. Thus, studies on the role of RNAs in
the aggregation and folding behavior of their interacting proteins
both in vitro and in vivo are required to understand de novo folding
inside the cells.
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2677Based on the apparent charge effect on protein solubility and the
foldinginduced byRNA binding,herewe provideevidenceofRNA-
interaction mediated protein solubility and folding enhancement.
When an RNA-binding domain (RBD) is fused to target proteins,
this domain, through binding with RNA, further promotes the
solubility of downstream passenger proteins in vivo,p o t e n t i a l l y
leading to a proper folding. The binding of highly negative-charged
RNA to RBD-harboring proteins during folding process would
promote the solubility and folding of whole proteins probably by
virtue of the electrostatic repulsions caused by the bound RNA
(Fig. 1a). In effect, RNA could exert efficient chaperoning effects on
itsbound proteins.Inaddition,RNA-bindingprotein(RBP)couldbe
powerful solubility enhancer for high-throughput soluble expression
of heterologous proteins through its interaction with RNA molecule.
Results
Development of RBPs as solubility enhancers
To explore potential chaperoning role of RNA for RBD-
harboring proteins, we initially tested several RBPs, including E.
Figure 1. Development of RBPs as solubility enhancers. (a) Proposed model for RNA binding-mediated protein folding. Both the folded RBD at
N-terminal position and bound RNA prevent inter-molecular interactions among folding intermediates, leading to soluble expression and favoring
kinetic network into productive folding. The number of black bars (| and I) represents the extent of aggregation inhibition. (b) The comparison of
solubility-enhancing ability by RBP with that of MBP. E. coli lysyl tRNA synthetase (LysRS) and influenza virus nucleoprotein (NP) were used as RBP to
monitor the soluble expression of tobacco etch virus (TEV) protease. The solubility-enhancing ability of RBP was compared to that of MBP. The fusion
proteins were expressed at 37uC and their solubility was analyzed by SDS-PAGE. M, T, S, and P represent molecular weight marker, total lysates,
soluble fraction, and insoluble fraction, respectively. (c) Autocatalytic cleavage of LysN-TEV containing TEV cleavage sequence between LysN and TEV
protease in E. coli cytosol. Non-induced (2) and IPTG induced (+) cell extracts were analyzed by SDS-PAGE. The uncleaved LysN-TEV was not detected
clearly on SDS-PAGE due to efficient cleavage. (d) Cell proliferation assay of GCSF expressed as LysN-GCSF. The purified TEV protease described in
Figure 1c was used to cleave the purified LysN-GCSF. The purified LysN, TEV protease, and LysN-GCSF before and after cleavage with TEV protease
were compared with the GCSF standard in the cell proliferation assay as described in Methods.
doi:10.1371/journal.pone.0002677.g001
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3/33) nucleoprotein (NP) that exhibits non-specific RNA-binding
properties [26], Ffh of signal recognition particle [27], C5 of
RNase P [28], and Hsp 15 [29]. MBP, known as one of the best
avenues to the soluble expression of fusion proteins so far [8], was
included as control. As a reporter protein, tobacco etch virus
(TEV) protease, mainly expressed as inclusion bodies without
fusion in E. coli [8], was used.
LysRS and NP-fused TEV protease were predominantly
expressed as a soluble form ($90%) at 37uC, whereas MBP-fused
TEV protease was marginally soluble, indicating that both LysRS
and NP are much superior to MBP for promoting the solubility of
TEV protease (Fig. 1b). The low expression of NP-TEV protease is
due to the low expression of NP protein itself (data not shown)
perhaps due to codon bias in E. coli host for the influenza virus
derived protein. Hsp15-TEV protease was expressed as a soluble
form (40%) at 37uC, and the solubility was greatly increased at 27uC
($90%) (Fig. S1). Likewise, the solubility of C5-fused TEV protease
was significantly increased at 27uC. All TEV fusion proteins
exhibited site-specific protease activity as confirmed by the cleavage
of LysN-fused human granulocyte colony-stimulating factor (LysN-
GCSF) containing TEV cleavage site at the linker region (Fig. S2).
LysRS is a homodimeric protein (114 kDa), and its monomer
consists of N-terminal (LysN) and C-terminal catalytic domains
[30]. The LysN domain binds to the anticodon of tRNA
Lys [31]
and was expected to serve as an independent RBD. We therefore
investigated whether LysN as a single RBD (N-terminal 154
residues of LysRS) exhibits chaperoning activity toward its target
proteins such as TEV protease and GCSF. From the initial LysN-
TEV fusion construct separated by a linker sequence containing
the TEV recognition site and histidine tag, two cleavage products
corresponding to mature TEV protease and the LysN domain
were produced (Fig. 1c). Moreover, the enzymatic activities of the
purified TEV proteases released from LysN-TEV and MBP-TEV
by autocatalytic cleavage and the commercially available TEV
protease (Invitrogen) were compared using LysN-GCSF as a
substrate. As shown in Figure S3, the enzymatic activities of three
TEV proteases are similar. The results suggest that the soluble
TEV protease released from LysN-TEV construct is correctly
folded, and that the mechanism of solubility and folding
enhancement is similar for different solubility enhancers. In
addition, the biological activity of the LysN-GCSF fusion protein
was tested on proliferation of target cells. The activity of the fusion
protein was about 100 fold lower than the standard possibly due to
steric hindrance of the RBD to GCSF receptor binding, but after
cleavage with TEV protease the activity increased significantly
comparable to that of standard (Fig. 1d). These results suggest that
the upstream RBD has the potential to facilitate the proper folding
as well as solubility of the downstream proteins in a cis-acting
manner.
RNA-mediated protein folding in vitro
To investigate the chaperoning role of RNA to the folding of the
RBD-harboring proteins, in vitro refolding of LysRS was performed
in the presence of cognate tRNA
Lys and the activity of refolded
LysRS was monitored by aminoacylation assay. The results
showed that the folding of LysRS into functionally active form was
significantly stimulated by the presence of its cognate tRNA
Lys as
compared to controls either without RNA or with non-cognate
RNAs such as yeast total RNA or yeast tRNA
Phe (Fig. 2a). Low,
but detectable level of stimulation by yeast tRNA
Phe may be due to
non-specific interactions among non-cognate tRNA and LysRS,
consistent with known nonspecific interactions between non-
cognate pairs of tRNA synthetases and tRNAs [32].
Because LysRS is large and dimerized protein, it is rather difficult
to directly investigate the role of tRNA in the folding process. To
simplify the system, LysN was used as a single independent RBD for
further studies. LysN was reported to specifically bind to the
anticodon of tRNA
Lys, with dissociation constant (kd) in the range of
10
24 M, about 10 fold higher than LysRS [31]. The LysN RBD was
fused to enhanced green fluorescent protein (EGFP) for monitoring
RNA binding-mediated protein folding. To ensure that the
chromophore is not formed, the EGFP fusion protein was initially
purifiedfrominclusion bodies andusedfor therefolding studies.The
refolding yield of LysN-EGFP was significantly increased by
tRNA
Lys in a concentration-dependent manner, whereas the
increase of refolding yield by yeast tRNA
Phe was only marginal (less
than 10%) (Fig. 2b and c). The results suggest that the binding
between LysN and its cognate tRNA contribute to the enhancement
of refolding of LysN-EGFP in vitro. In contrast, the refolding yield of
MBP-EGFP was little affected by tRNA
Lys (Fig. 2b). These results
demonstrate that the binding of tRNA
Lys to LysN RBD promotes
the folding of downstream EGFP, implying the chaperoning activity
of tRNA
Lys on the folding of LysN-EGFP.
RNA-mediated solubility enhancement in vivo
Site-directed mutagenesis studies were performed to assess the
contribution of tRNA
Lys binding to LysRS to the solubility
enhancement in vivo. The residues at position 130 and 133 in
LysRS, predicted to interact with tRNA
Lys [31] were replaced with
alanine, yielding single point mutants of LysRS(K130A) and
LysRS(T133A). The mutations in LysRS at position 130 or 133 in
themselves did not affect the solubility of the mutant LysRS
proteins (Fig. 3a). We then fused the LysRS mutants with three
independent aggregation-prone passenger proteins such as
GNB2L1, ANGPTL4 and FAM3D, the information of which
are described in detail (Table S1). As shown in Figure 3b, the
solubility of LysRS (K130A) fusion proteins was greatly reduced
for all three passenger proteins tested whereas that of
LysRS(K133A) was not changed or even slightly higher in some
cases, as compared with that of LysRS fusion proteins.
We then performed the analysis of the interaction between
LysRS and tRNA
Lys by gel-retardation assay. The affinity of
LysRS(K130A) to tRNA
Lys was significantly reduced whereas that
of LysRS(K133A) was not or even slightly increased (the amount of
radiolabeled tRNA
Lys bound to K130A and K133A was approx-
imately 0.35 and 1.17, respectively, when the amounts of bound
tRNA
Lys to wt LysRS were set to 1 (left panel in Fig. 3c)). The
competition assays with unlabeled tRNAs showed that the binding
was effectively reduced by the cognate E. coli tRNA
Lys for all three
LysRS constructs, WT, K130A and T133A (middle panel, Fig. 3c)
whereas the non-cognate yeast tRNA
Phe competed less efficiently
(right panels, Fig. 3c). The results in Figure 3 confirm that the
solubility enhancement of passenger proteins by LysRS is directly
related to the binding affinity of LysRS to tRNA
Lys.
The contribution of RNA binding to the solubility enhancement
was further confirmed in vivo by coexpression of tRNA
Lys. Here,
the expression of tRNA
Lys was under the control of T7 promoter
and induced by IPTG, whereas the expression of LysRS-GNB2L1
fusion protein was under the control of arabinose promoter in a
separate vector and induced by arabinose. The coexpression of
tRNA
Lys significantly increased the solubility of LysRS-GNB2L1
whereas the coexpression of non-cognate E. coli tRNA
Phe has little
or no effect (Fig. 3d). In addition, the coexpression of tRNA
Lys did
not affect the solubility of LysRS(K130A)-GNB2L1. The results in
Figure 3 demonstrate that the binding of cognate tRNA to LysRS
plays a key role in solubility enhancement of LysRS-fused
passenger proteins in vivo.
RNA-Mediated Protein Folding
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and MBP
If RNA-mediated protein solubility enhancement is what could
be observed for RNA binding proteins in general, it could be
argued that most of ‘difficult to express’ proteins that by
themselves are expressed as misfolded insoluble aggregates could
now be expressed as soluble form by fusion to RBD. As a proof of
principle, we therefore fused variety of proteins of mammalian
origin to RBD and examined the soluble yield and compared with
the classic solubility enhancing carrier protein MBP as a control.
For this purpose, nineteen human proteins potentially related to
the progression of gastric or liver cancers and three mouse proteins
were tested [33–35]. The information of test proteins is
summarized (Table S1). These proteins are diverse in location
(cytoplasmic, organellar, and extracellular), pI (lowest pI=3.94,
L259, highest pI=9.52, MIC-1), and molecular weight (lowest
MW=16 kDa, LECT2, highest MW=61 kDa, CYP1B1). The
Figure 2. RNA-mediated protein folding in vitro. (a) In vitro refolding of LysRS. The refolding of LysRS was performed in the presence of E. coli
tRNA
Lys (2 mM), yeast tRNA
Phe (2 mM) or yeast total RNA (the amount equivalent to 2 mMo fE. coli tRNA
Lys), and then the enzymatic activity of
refolded LysRS was investigated using aminoacylation assay, as described in Methods. (b) In vitro refolding of LysN-EGFP. Refolding of LysN-EGFP was
performed in vitro in the presence of E. coli tRNA
Lys or yeast tRNA
Phe. The fluorescence emission of refolded LysN-EGFP was continuously monitored.
As a control, MBP-EGFP was tested under the same condition. (c) The effects of tRNAs on the refolding yield at 100 min in (b) were compared and
summarized. The fluorescence intensity in the absence of tRNA was set to 100%.
doi:10.1371/journal.pone.0002677.g002
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PLoS ONE | www.plosone.org 4 July 2008 | Volume 3 | Issue 7 | e2677Figure 3. Correlation between RNA binding and solubility enhancement. (a) Expression of unfused wt LysRS, LysRS(K130A), and
LysRS(T133A) at 37uC. These proteins have hexa-histidine tag at their C-termini. Mutants were constructed using PCR overlapping mutagenesis. (b)
The effects of point mutations on the solubility of LysRS fusion proteins in vivo. Three passenger proteins GNB2L1, ANGPTL4 and FAM3D were fused
to the C-termini of wt LysRS, LysRS(K130A), and LysRS(T133A). The expression temperature was 37uC (30uC in case of FAM3D fusion proteins). The
representative SDS-PAGE data are shown in left panel. The solubility of fusion proteins obtained by three independent experiments is summarized in
right panel. (c) RNA binding analysis of LysRS and its mutants using gel-retardation assay. The binding affinity of wt LysRS, LysRS(K130A), and
RNA-Mediated Protein Folding
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out of 22 cases) or were refractory to soluble expression (14 out of
22 cases) (data not shown). The SDS-PAGE results corresponding
to the total, soluble, insoluble fractions of LysRS- or MBP-fused
proteins expressed at 30uCo r3 7 uC were shown in Figure 4a.
Soluble yields are now compared among the three expression
methods (direct expression, LysRS- and MBP-fusion) (Fig. 4b).
The results clearly demonstrate that most proteins could be
expressed as soluble form by fusion to LysRS, and interestingly
enough, LysRS is generally much more superior to MBP for
gaining and enhancing the solubility (21 out of 22 cases). It should
also be noted that eight of the test proteins (e.g., ANGPTL4,
CXX1, FAM3D, HPR, L259, LECT2, MIC-1 and PTTG1IP)
failed to be expressed up to detection level when expressed without
fusion. This means that the particular RBD used here (E. coli
LysRS) promotes expression level as well as solubility of passenger
proteins.
All LysRS-fused proteins in Figure 4 were purified via one-step
Ni-affinity chromatography. As shown in Figure 5, the target
proteins were efficiently released from the fusion proteins by
cleavage of TEV protease with minor exceptions (LysRS-FAM3D
and LysRS-L259). The results show that the RNA-mediated
solubility enhancement is extremely robust for soluble expression
of heterologous proteins that are prone to aggregate in E. coli.
Discussion
In this study, we showed that RNA can exert chaperoning effect
on the folding of its bound proteins. The result was confirmed
through in vitro refolding of E. coli LysRS and LysN-EGFP in the
presence of cognate or non-cognate RNA (Fig. 2) and RNA
coexpression in vivo on the solubility of LysRS-fused proteins
(Fig. 3d). Site-directed mutagenesis of amino acid residues in
LysRS involved in RNA binding further confirmed the impor-
tance of RNA interaction for the solubility enhancement (Fig. 3b
and c). Our results suggest that RNA, a highly soluble polyanionic
macromolecule, can increase the solubility of its bound aggrega-
tion-prone proteins during the folding process. If the solubility
enhancement by RNA is its intrinsic property, the contribution of
RNA to de novo folding in vivo would be greater than we expect,
which will be further discussed. Technically, the data presented
here further provides a rationale for the development of RBPs as
robust solubility enhancers, very useful for high-throughput
soluble expression of eukaryotic proteins [36–38].
How does RNA promote the solubility and folding of RBD-fused
proteins? Polyanionic tags have been known to promote the
solubility of their linked proteins [16,17]. Net charge of solubility
enhancers are an important for their solubilizing ability on their
passenger proteins [18,19]. In particular, it was suggested that the
electrostatic repulsions of polyanionic surfaces of folded N-terminal
solubility enhancer could contribute to the solubility of their
downstream polypeptides [18]. It is conceivable, therefore, that the
highly negative-charged RNA (75 negative charges in the case of 76
ntlongtRNA
Lys)boundtothefoldedN-terminalRBDwouldgreatly
increase the intermolecular electrostatic repulsions, leading to the
promotion of solubility and consequent folding of RBD-fused
proteins. This mechanism appears to be in good accordance with
the obvious charge effect on protein solubility [12–19].
Another possibility to consider is that RNA functions as a
specific ligand to bound protein, and the binding of RNA to
folding intermediate actually dictates the bound protein to fold
into a specific conformation [13,39,40]. For example, tRNA
Lys
(Fig. 2b) might direct folding of LysN of LysN-EGFP, and then the
folded LysN might function as a solubility enhancer toward the C-
terminal EGFP. It is also possible that folding enhancement of
LysN by tRNA
Lys prevent unfolded LysN from interfering with
folding of down-stream EGFP. However, these explanations does
not appear to be satisfactory since LysN and LysRS are known to
form their own stable three dimensional structures in the absence
of tRNA [30,31], and LysN alone efficiently fold in a two-state
Figure 4. Comparison of the solubility of MBP and LysRS fusion
proteins. (a) SDS-PAGE corresponding to the total, soluble and insoluble
fractions of fusion proteins. (b) The summary of the solubility of directly
expressed proteinsand their fusionproteins. The proteins were expressed
either at 37uCo ra t3 0 uC( A P 1 M 2 ,C X X 1 ,F A M 3 D ,H P R ,m V D U P 1 ) .T h e
bands of MBP-CXX1 and MBP-LECT2 were not detectable on the SDS-
PAGE. The expression cassette of fusion proteins comprises LysRS (or
MBP)-D6-SG-ENLYFQ-MCS-H6 where the sequence of ENLYFQ, MCS, and
H6 are TEV protease recognition site, multi-cloning site of KpnI-BamHI-
EcoRV-SalI-HindIII, and C-terminal hexahistidine tag, respectively.
doi:10.1371/journal.pone.0002677.g004
LysRS(T133A) to 59-
32P-labeled tRNA
Lys was analyzed by gel-retardation assay as described in Methods. For the competition assay, the cold tRNA
Lys
(middle) and tRNA
Phe (right) of various concentrations (0, 0.46, 1.16, and 2.3 mM) was used. Arrow indicates the LysRS-tRNA
Lys complexes. Note that
the relative amounts of tRNA
Lys binding to LysRS, LysRS(K130A), and LysRS(T133A) are 1, 0.35, and 1.17, respectively. (d) The effect of tRNA
coexpression on the solubility of LysRS fusion proteins in vivo. GNB2L1 as a C-terminal passenger protein was fused to wt LysRS and LysRS(K130A),
and the fusion proteins were expressed at 37uC.
doi:10.1371/journal.pone.0002677.g003
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folding of LysN and LysRS cannot be completely excluded.
Could the RNA-mediated chaperone-like type be extended to de
novo folding of native proteins in vivo? RNA constitutes a major class
of macromolecules inside cells [42], and there are varieties of RNA-
binding proteins that generally exhibit significant non-specific
affinity [32], which lends credence to ubiquitous nature of RNA-
mediated protein folding inside the cells. More importantly, all
cytosol-exposed nascent polypeptides on the ribosome of a gigantic
RNP complex, prior to formation into stable structure, have been
believed to be highly aggregation-prone in the crowded cytosol
[43,44], and are expected to be protected by ribosome-associated
molecular chaperones in vivo [45]. Extensive analysis so far has
revealed that most proteins fold independent of the molecular
chaperones [2–5], which poses a challenge in de novo folding of
proteins in vivo. So far, however, the potential effects of ribosome, a
gigantic RNP complex, on the aggregation behavior of its linked
nascent polypeptide have notbeen given proper attention.The RNP
complex (RNA and RBD)-linked aggregation-prone proteins herein
described essentially mimics the ribosome-linked nascent polypep-
tides. Accordingly, it is tempting to speculate that ribosome itself
might contribute to the solubility enhancement of its linked
aggregation-prone nascent polypeptide in a cis-acting manner. If
generallylargeRNAexhibitsitsintrinsicabilitytosolubilizeitslinked
polypeptides irrespective of the ligand effect, the present RNA-
mediated chaperone type has the potential to play an important role
in de novo folding inside the cells.
The post-genome research initiatives on structural proteomics
require a robust technical platform for protein expression. So far,
expression of functionally active proteins in E. coli remains a
formidable task despite extensive use of molecular chaperones or
solubility-enhancing fusion carriers. The soluble expression of
variety of proteins of mammalian origin herein presented is
extremely robust and could usefully be implemented for high-
throughput protein expression for functional and structural genomic
research initiatives. While giving new insights into protein folding
inside the cells, the present report provides a user-friendly method
for protein expression for both analytical level and commercial
production and will significant impact on human proteome analysis,
target identification and validation for new drug targets.
Materials and Methods
Materials
E. coli tRNA
Lys, yeast tRNA
Phe, and yeast total RNA were
purchased from Sigma. The enzymes used for DNA manipulation
were purchased from New England Biolabs.
Construction of protein expression vectors
E. coli lysS gene encoding lysyl-tRNA synthetase was cloned into
NdeI/HindIII sites of a derivative plasmid of pGEMEX-1 (Promega)
in which one of two NdeI sites is deleted, yielding the plasmid, pGE-
LysRS. The LysRS expression cassette includes LysRS-enterokinase
recognition site-multicloning sites of KpnI-BamHI-EcoRV-SalI-Hin-
dIII under the T7 promoter. The plasmid pGE-LysRS was used for
the construction of plasmids shown in Figure 1.
Structural genes for E. coli C5 of RNase P, Ffh of signal
recognition particle, Hsp15, and MBP without signal peptide were
Figure 5. Generation of target proteins from the fusion proteins. Twenty two LysRS fusion proteins purified on one-step Ni-affinity
chromatography were incubated at 30uC for 2 h in 30 ml containing 50 mM Tris–HCl, pH 8.0, 0.5 mM EDTA, 1 mM DTT with 1 unit of TEV protease
(Invitrogen). All samples were analyzed by SDS-PAGE. The arrow indicates the released target proteins.
doi:10.1371/journal.pone.0002677.g005
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specific primers for each gene. The NP gene of influenza A virus
was obtained from PCR amplification of influenza vRNAs using
the following primers; 59 GTC ATC GTC ATC CAT ATG GCG
TCT CAA GGC ACC AAA CGC TC 39 as sense primer, and 59
GTC ATC GGT ACC ATT GTC GTA CTC CTC TGC ATT
GTC TCC 39 as antisense primer. The obtained PCR fragments
encoding fusion partners were cleaved with NdeI/KpnI and inserted
into NdeI/KpnI sites of pGE-LysRS, yielding each fusion vector.
The gene encoding tobacco etch virus (TEV) protease with N-
terminal histidine tag was amplified using the following primers; 59
GTC ATCA GGA TCC GGT CAT CAT CAT CAT CAT CAT
CAT GGA GAA AGC TTG TTT AAG 39 as sense primer, and
59 GTC ATC GTC GAC TTA TTA ATT CAT GAG TTG
AGT CGC TTC C 39 as antisense primer. The TEV protease
gene was inserted into BamHI/SalI sites of each fusion vector to
express TEV fusion proteins. The gene encoding mature GCSF
was obtained from the plasmid, pIL20GC [46]. Each gene
encoding LysN-EGFP, MBP-EGFP, LysN-TEV, and LysN-GCSF
were cloned into the pGE-LysRS.
For the comparison of solubility-enhancing ability between
LysRS and MBP in Figure 4, the modified expression vector of
pGE-LysRS, which carries LysRS (or MBP)-D6-SG-ENLYFQ-
MCS-H6 in place of LysRS-enterokinase recognition site-MCS,
was used. However, in case of plasmid pAra-LysRS-GNB2L1 and
pAra-LysRS(K130A)-GNB2L1 used in Figure 3d, T7 promoter
was replaced with arabinose promoter.
Construction of tRNA coexpression vector
For coexpression of E. coli tRNA
Lys or E. coli tRNA
Phe, DNA
fragments containing the T7 promoter-matured E. coli tRNA
Lys (or
E. coli tRNA
Phe) gene-T7 terminator was ligated into the SalI/SphI
site of plysE (Novagen), yielding pE-tRNA
Lys and pE-tRNA
Phe,
respectively.
Protein expression
The protein expression, SDS-PAGE analysis, and solubility
measurement were performed as described previously [18]. Each
expression vector was transformed into the E. coli expression host,
HMS174(DE3)plysE (Novagen). A single colony of transformants
was inoculated into 2 ml of LB containing both 50 mg/ml
ampicillin and 30 mg/ml chloramphenicol, then diluted into
20 ml of the fresh LB. Cells were cultured till the optical density
(OD) reached to 0.5 at 600 nm. Proteins were expressed for 3 h
after the addition of 1 mM IPTG. The harvested cells from 10 ml
of culture broth were suspended in 0.3 ml of PBS, lysed by
sonication. Fifty ml of total lysates was mixed with the same volume
of 2 X SDS loading buffer. To separate soluble and pellet
fractions, the remaining total lysates were centrifuged at
13,000 rpm for 12 min. The insoluble pellet fractions were
resuspended with PBS of the same volume of soluble fractions.
Fifty ml of soluble fractions and insoluble pellet fractions were
mixed with 50 ml of 2 X SDS loading buffer. After boiling, the
samples were loaded and run on SDS-PAGE. The loading
amounts of samples were normalized by final cell OD600 nm. The
gels were stained with Coomassie brilliant blue R-250. The
solubility of proteins of interest was estimated on SDS-PAGE using
Bio-1D image analysis software (Vilber Lourmat).
To coexpress tRNAs, the RNA expression plasmid (pE-tRNA
Lys
or pE-tRNA
Phe) and the protein expression plasmid (pAra-LysRS-
GNB2L1 or pAra-LysRS(K130A)-GNB2L1) was co-transformed
into the expression host HMS174(DE3). After addition of 0.5 mM
IPTG to the growing cells at the OD600 nm of 0.5, the cells were
cultured for 30 min, and then 0.02% L-arabinose was added to
induce the expression of fusion proteins. After 3h culture, the cells
were harvested.
Purification of proteins
Proteins were purified from 1 L culture of each transformant
using nickel affinity chromatography. After addition of 5 ml of the
equilibrium buffer A (20 mM Tris-HCl (pH 7.5), 300 mM NaCl,
10% glycerol, 2 mM 2-mercaptoethanol, and 5 mM imidazole) to
the harvested cells, the resuspended cells were disrupted by
sonication. The soluble fractions were obtained by centrifugation
at 30,000 g for 20 min twice and then applied onto HiTrap
chelating HP column (5 ml, Amersham Biosciences). After
washing, proteins were eluted with 50 ml linear gradients of
imidazole ranging from 5 to 300 mM. The fractions containing
proteins of interest were pooled and concentrated with Centriprep
(Amicon), and dialyzed against the buffer containing 100 mM
Tris-HCl (pH 8.0), 100 mM NaCl, 2 mM EDTA, and 2 mM
DTT, mixed with the same volume of 100% glycerol. The purified
proteins were stored at 220uC until use. For the purification of
proteins from inclusion bodies, the cells resuspended in buffer A
were lysed by sonication, and then insoluble proteins were
obtained by centrifugation. Inclusion bodies were then solubilized
in buffer A containing 6 M guanidine-HCl. After centrifugation at
30,000 g for 20 min, the supernatant fractions were collected and
loaded on HiTrap chelating HP.
In vitro refolding of LysRS
The purified LysRS with 6 consecutive histidine residue at its C-
terminus was denatured in 6 M guanidine-HCl, 1 mM DTT, and
20 mM Tris-HCl (pH 7.8), to a final concentration of 1.3 mM for
2 h at 37uC. The denatured proteins were 50 fold diluted into the
refolding buffer containing 20 mM Tris-HCl (pH 7.8), 1 mM
DTT, 50 mM NaCl, 1 mM MgCl2, and various RNA (2 mMo r
equivalent to 2 mM E. coli tRNA
Lys) and incubated for 1.5 h at
25uC. The enzyme activity of refolded LysRS was analyzed by
aminoacylation assay of LysRS as described previously [25]. The
refolding mixture was 10 fold diluted into the aminoacylation
assay buffer (total volume of 100 ml) containing 20 mM Tris-HCl
(pH 7.8), 150 mM KCl, 2 mM ATP, 0.1 mM EDTA, 7 mM
MgCl2,1mCi of L-[
14C]-lysine, and 3.7 mM tRNA
Lys at 30uC. At
different time intervals, 10 ml of reaction mixture was mixed with
the same volume of 10% (w/v) ice-cold trichloroacetic acid
(Sigma), placed on ice for 10 min. The precipitates were filtered
through Whatman No.2 filter paper, and washed once with 95%
ethanol, followed by air drying. The bound [
14C]-lysine was
determined with liquid scintillation counter (Beckman).
In vitro refolding of LysN-EGFP and MBP-EGFP
The EGFP fusion proteins purified under the denaturation
conditions were incubated in 6 M guanidine-HCl and 1 mM
DTT for 20 min at 40uC. The refolding buffer was as described
previously [47]. The denatured proteins were 50 fold diluted into
the refolding buffer containing 50 mM MOPS (pH 7.0), 100 mM
KCl, 5 mM DTT, 5 mM magnesium acetate, 0.2 mg/ml BSA
and indicated RNA. The reaction mixtures were incubated at
30uC, and the fluorescence intensity of the refolded EGFP was
monitored with excitation at 490 nm and emission at 510 nm
using fluorescence spectrophotometer (Varian).
Cell proliferation assay of GCSF
To investigate the proper folding of downstream protein in
RBD-fusion context, in vitro assay was performed for both LysN-
GCSF and GCSF released from the fusion protein after TEV
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Mouse myeloid leukemia cell line NFS-60 [48] was cultured in
RPMI-1640 containing 10% fetal bovine serum and 2.5 ng/ml
GCSF (obtained from CJ Ltd, Korea). After washing the harvested
cells with PBS three times, the cells were resuspended in culture
medium without GCSF. Test proteins were serially diluted in assay
medium, transferred to 96-well plate (50 ml each), and mixed with
the same volume of the prewashed cell suspensions in the density
of 1610
5 cells/ml. Plates were incubated at 37uC for 48 h. After
addition of 10 ml of the MTT solution, the plates were further
incubated for 4 h before quenching by acidified solution
containing isopropanol. The absorbance was measured at
550 nm with ELISA reader (Tecan). The mean value of
absorbance was converted to international unit (IU) using the
standard GCSF as a reference.
Gel-retardation assay
E. coli tRNA
Lys (Sigma) was treated with alkaline phosphatase
(Roche). After heat inactivation of alkaline phosphatase, tRNA
Lys
was labeled with [c-
32P]ATP(3000 Ci/mmol) (PerkinElmer) by T4
kinase. The 59-
32P-labeled tRNA
Lys was purified using Sephadex
G25 column (Roche). The interactions of purified LysRS and its
variants with radiolabeled tRNA
Lys were assayed by gel-retarda-
tion assay as described previously [49]. The binding reaction was
performed in 20 ml buffer (20 mM Tris-HCl pH 7.5, 150 mM
NaCl, 10 mM MgCl2, 10 mM 2-mercaptoethanol, 10% glycerol,
and bovine serum albumin at 0.1 mg/ml) at 25uC for 20 min.
After electrophoresis on 6% polyacrylamide gel containing 5%
glycerol and 0.5 X TBE at 4uC, the fixed and dried gels were
subjected to autoradiography.
Supporting Information
Figure S1 Enhancement of solubility of proteins by fusion to
RNA-binding proteins. The tested proteins include E. coli C5, Ffh
of signal recognition particle, and Hsp15. TEV protease was fused
to the C-terminus of each RBP. Fusion proteins were expressed at
37uC and 27uC, and the solubility of fusion proteins were analyzed
by SDS-PAGE. T, S, and P represent the total extract, soluble
fractions, and insoluble fractions, respectively.
Found at: doi:10.1371/journal.pone.0002677.s001 (0.62 MB TIF)
Figure S2 Functional assay of RNA-binding protein (RBP)-fused
TEV. To check the proper folding of RBP-fused TEV proteins,
purified LysN-GCSF fusion protein carrying linker peptide of
TEV recognition site was used as substrate. All RBP-fused TEV
proteins were purified via nickel affinity column (data not shown).
The cleavage reaction was performed in 30 ml of reaction volume
containing 50 mM Tris-HCl (pH 8.0), 0.5 mM EDTA, 1 mM
DTT, 6 mg of LysN-GCSF as substrate, and each RBP-fused TEV
protein for 1h at 30uC. The reaction products were analyzed by
SDS-PAGE.
Found at: doi:10.1371/journal.pone.0002677.s002 (0.62 MB TIF)
Figure S3 Functional assay of TEV proteases. (a) The tested
TEV proteases. The released TEV proteases from LysN-TEV and
MBP-TEV by autocatalytic cleavage in vivo (nTEV and mTEV,
respectively) were purified by one-step Ni-affinity chromatogra-
phy. The commercially available rTEV (Invitrogen) was used as a
positive control. (b) The activities of TEV proteases. The TEV
protease cleavage reaction was carried out in 120 ml of reaction
volume containing 50 mM Tris-HCl (pH 8.0), 0.5 mM EDTA,
1 mM DTT, 30 mg of LysN-GCSF as substrate, and 2 mg each
TEV protease at 30uC. Twenty ml of the reaction mixture was
sampled at indicated time intervals (10, 20, 40, and 80 min). These
samples and uncleaved substrate (named S) were analyzed by
SDS-PAGE. (c) The extent of substrate cleavage was estimated on
the above SDS-PAGE by densitometric scanning. In the present
experimental conditions, the amount of the cleaved substrate (mg)
by one mg of each TEV protease (rTEV, nTEV and mTEV) for
1 min was approximately 0.27, 0.25, and 0.24, respectively.
Found at: doi:10.1371/journal.pone.0002677.s003 (1.81 MB TIF)
Table S1 The information of 22 proteins used in Figure 3 and 4.
Unigene is a system for partitioning GenBank sequences into a
nonredundant set of gene clusters, and Reference sequences
(RefSeq) database provides references for transcripts, proteins, and
genomic regions on NCBI.
Found at: doi:10.1371/journal.pone.0002677.s004 (1.76 MB TIF)
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